<html>
<head>PUBMED IDs for RLX1</head>
<body bgcolor='#C5F0F2'><h1>RLX1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/25524310/'>Translational impact of nanoparticle-drug conjugate CRLX101 with or without bevacizumab in advanced ovarian cancer.</a> December 15  2014<br></body></html>
